Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ESMO open

Showing results (41-50 of 2,236) with videos related to

Pageof 224
Sort By:
ESMO Open|March 19, 2022
Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancersJ Tabernero, F Andre, J-Y Blay, et al.
ESMO Open|April 11, 2022
Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapyE Grande, T Alonso-Gordoa, O Reig, et al.
ESMO Open|April 10, 2022
Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trialsD König, S Schär, D Vuong, et al.
ESMO Open|April 2, 2022
Cancer-related fatigue and depression: a monocentric, prospective, cross-sectional study in advanced solid tumorsR Lobefaro, S Rota, L Porcu, et al.
ESMO Open|March 6, 2022
MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapyR Bodensohn, R Forbrig, S Quach, et al.
ESMO Open|March 10, 2022
How I treat HER2-positive early breast cancer: how long adjuvant trastuzumab is needed?S Morganti, G Bianchini, A Giordano, et al.
ESMO Open|March 10, 2022
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinomaM Laganà, S Grisanti, R Ambrosini, et al.
ESMO Open|June 25, 2019
New emerging targets in cancer immunotherapy: the role of LAG3Hannah Christina Puhr, Aysegül Ilhan-Mutlu
ESMO Open|June 25, 2019
In the literature: April 2019Gema Bruxiola, Juan-Miguel Cejalvo, Valentina Gambardella, et al.
ESMO Open|June 25, 2019
Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implicationsCarolina Martinez-Ciarpaglini, Tania Fleitas-Kanonnikoff, Valentina Gambardella, et al.
Pageof 224

Showing results (41-50 of 2,236) with videos related to

Sort By:
Pageof 224
ESMO Open|March 19, 2022
Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancersJ Tabernero, F Andre, J-Y Blay, et al.
ESMO Open|April 11, 2022
Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapyE Grande, T Alonso-Gordoa, O Reig, et al.
ESMO Open|April 10, 2022
Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trialsD König, S Schär, D Vuong, et al.
ESMO Open|April 2, 2022
Cancer-related fatigue and depression: a monocentric, prospective, cross-sectional study in advanced solid tumorsR Lobefaro, S Rota, L Porcu, et al.
ESMO Open|March 6, 2022
MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapyR Bodensohn, R Forbrig, S Quach, et al.
ESMO Open|March 10, 2022
How I treat HER2-positive early breast cancer: how long adjuvant trastuzumab is needed?S Morganti, G Bianchini, A Giordano, et al.
ESMO Open|March 10, 2022
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinomaM Laganà, S Grisanti, R Ambrosini, et al.
ESMO Open|June 25, 2019
New emerging targets in cancer immunotherapy: the role of LAG3Hannah Christina Puhr, Aysegül Ilhan-Mutlu
ESMO Open|June 25, 2019
In the literature: April 2019Gema Bruxiola, Juan-Miguel Cejalvo, Valentina Gambardella, et al.
ESMO Open|June 25, 2019
Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implicationsCarolina Martinez-Ciarpaglini, Tania Fleitas-Kanonnikoff, Valentina Gambardella, et al.
Pageof 224